TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 P&L / Income Statement

TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. Consolidated revenue, costs and expenses.

Collaboration revenue

0 US dollars

Total operating expenses

59,785,000 US dollars

Loss from operations

negative 59,785,000 US dollars

Total other income, net

4,445,000 US dollars

Loss before income taxes

negative 55,340,000 US dollars

Provision for income taxes

1,000 US dollars

Net loss

negative 55,341,000 US dollars

Total operating expenses

59,785,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.